Scientists test new drug cocktails in fight against advanced cancers

NCT ID NCT02499328

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study tested new combinations of experimental drugs for people with advanced cancers that had stopped responding to standard treatments. It first aimed to find safe doses in patients with various solid tumors. It then focused on people with advanced head and neck cancer to see if these drug combinations could help shrink their tumors and control the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS & METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Birmingham, Alabama, 35294, United States
Research Site

Duarte, California, 91010, United States
Research Site

La Jolla, California, 92093, United States
Research Site

Los Angeles, California, 90024, United States
Research Site

Los Angeles, California, 90089, United States
Research Site

Orange, California, 92868-3298, United States
Research Site

San Francisco, California, 94158, United States
Research Site

Denver, Colorado, 80218, United States
Research Site

Plantation, Florida, 33324, United States
Research Site

Sarasota, Florida, 34232, United States
Research Site

Lafayette, Indiana, 47905, United States
Research Site

Boston, Massachusetts, 02111, United States
Research Site

Detroit, Michigan, 48201, United States
Research Site

Billings, Montana, 59101, United States
Research Site

Morristown, New Jersey, 07960, United States
Research Site

Cincinnati, Ohio, 45267-2827, United States
Research Site

Houston, Texas, 77030, United States
Research Site

Fairfax, Virginia, 22031, United States
Research Site

Seattle, Washington, 98109, United States
Research Site

Antwerp, 2020, Belgium
Research Site

Brussels, 1000, Belgium
Research Site

Brussels, 1200, Belgium
Research Site

Edegem, 2650, Belgium
Research Site

Namur, 5000, Belgium
Research Site

Berlin, 12200, Germany
Research Site

Cologne, 50670, Germany
Research Site

Dresden, 1307, Germany
Research Site

Frankfurt, 60488, Germany
Research Site

Hamburg, 20246, Germany
Research Site

Hanover, 30625, Germany
Research Site

Jena, 07743, Germany
Research Site

München, 81675, Germany
Research Site

Milan, 20133, Italy
Research Site

Barcelona, 08035, Spain
Research Site

Hospitalet deLlobregat, 08907, Spain
Research Site

Madrid, 28040, Spain
Research Site

Madrid, 28041, Spain
Research Site

Toledo, 45004, Spain
Research Site

Birmingham, B15 2TH, United Kingdom
Research Site

London, SE1 9RT, United Kingdom
Research Site

London, SW3 6JB, United Kingdom
Research Site

Manchester, M20 4BX, United Kingdom
Research Site

Surrey, SM2 5PT, United Kingdom
Research Site

Taunton, TA1 5DA, United Kingdom

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS & METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK